Valiant Laboratories Ltd Quarterly Results

Gross Sales

35.23

21.48

18.88

30.59

40.52

Excise Duty

0

0

0

0

0

Net Sales

35.23

21.48

18.88

30.59

40.52

Other Operating Income

0

0

0

0

0

Other Income

1.58

3.36

2.81

2.5

1.78

Total Income

36.81

24.84

21.7

33.09

42.29

Total Expenditure

34.61

28.22

21.27

35.12

46.82

PBIDT

2.2

-3.38

0.43

-2.03

-4.53

Interest

0.06

0.01

0.05

0.02

0.02

PBDT

2.14

-3.39

0.37

-2.05

-4.55

Depreciation

0.52

0.52

0.53

0.52

0.49

Minority Interest Before NP

0

0

0

0

0

Tax

0.16

0.07

0.19

-1.58

-1.34

Deferred Tax

-0.88

0.76

0.16

0.25

-0.21

Reported Profit After Tax

2.35

-4.74

-0.51

-1.24

-3.5

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

2.35

-4.74

-0.51

-1.24

-3.5

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

2.35

-4.74

-0.51

-1.24

-3.5

EPS (Unit Curr.)

0.54

-1.09

-0.13

-0.33

-0.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

43.45

43.45

43.45

43.45

43.45

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

6.24

-15.73

2.27

-6.63

-11.17

PBDTM(%)

6.07

-15.78

1.95

-6.7

-11.22

PATM(%)

6.67

-22.06

-2.7

-4.05

-8.63